A chiral microenvironment promotes retinal progenitor cell proliferation by activating the Akt and ERK pathways. (31st August 2022)

• Record Type: Journal Article
• Authors: Sun, Na; Wang, Jiajing; Dou, Xiaoqiu; Wang, Yiqi; Yang, Yuan; Xiao, Dong; Zhao, Peiquan; Li, Jing; Wang, Shuting; Gu, Ping; Ji, Jing
• Is Part Of: Biomaterials science. Volume 10:Number 20(2022)
• Page Start: 5938
• Page End: 5946
• Publication Date: 2022-08-31
• Subjects: Biomedical materials -- Periodicals; 610.28
• DOI: 10.1039/d2bm00886f
• Languages: English
• ISSNs: 2047-4830

Abstract

Abstract : A schematic of the chiral effect on retinal progenitor cells (RPCs) cultured on right-handed helical DP nanofibers. The promotion of RPC proliferation is achieved on the right-handed helical DP nanofibers. Abstract : Retinal progenitor cell (RPC) transplantation has been proposed as a potential strategy for the treatment of retinal degeneration, which is a leading cause of vision loss. However, a major obstacle is the poor proliferation of RPCs. Accumulating evidence suggests that the chiral features of the extracellular microenvironment are closely related to cell proliferation. Inspired by this, l /d -phenylalanine-derived molecules (LP and DP) are employed to construct a biomimetic chiral microenvironment for enhancing RPC proliferation. LP and DP self-assemble into left-handed and right-handed helical fibrous networks, respectively. It is found that DP nanofibrous films show an excellent ability in promoting RPC proliferation via the activation of the Akt and extracellular signal-regulated kinase (ERK) pathways. In addition, both LP and DP nanofibrous films have the advantage of attenuating inflammation, and LP films can maintain the stem potential of RPCs. Thus, the promotion of RPC proliferation using a bioinspired chiral fibrous microenvironment is a promising strategy for RPC-based therapies for retinal degeneration.